<p><strong>Quest Diagnostics</strong>（纽约证券交易所代码：DGX）将于 2026 年 2 月 10 日发布最新的季度财报。在公告之前，投资者需要了解以下信息。</p>
<p>分析师预计 Quest Diagnostics 的 <strong>每股收益</strong>（EPS）为 2.35 美元。</p>
<p>投资者对 Quest Diagnostics 的公告充满期待，希望听到超出预期的消息以及对下个季度的积极指引。</p>
<p>新投资者应理解，虽然盈利表现很重要，但市场反应往往受到指引的驱动。</p>
<h3>盈利历史快照</h3>
<p>在上一次财报发布中，公司每股收益超出预期 0.09 美元，导致随后的交易日股价下跌 1.88%。</p>
<p>以下是 Quest Diagnostics 的过往表现及其导致的价格变化：</p>
<table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th align="right"><strong>2025 年第三季度</strong></th>
<th align="right"><strong>2025 年第二季度</strong></th>
<th align="right"><strong>2025 年第一季度</strong></th>
<th align="right"><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS 预估</strong></td>
<td align="right">2.51</td>
<td align="right">2.57</td>
<td align="right">2.15</td>
<td align="right">2.18</td>
</tr>
<tr>
<td><strong>EPS 实际</strong></td>
<td align="right">2.60</td>
<td align="right">2.62</td>
<td align="right">2.21</td>
<td align="right">2.23</td>
</tr>
<tr>
<td><strong>价格变化 %</strong></td>
<td align="right">-2.00</td>
<td align="right">-4.00</td>
<td align="right">0.00</td>
<td align="right">-1.00</td>
</tr>
</tbody>
</table>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1770656474_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="eps graph" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1770656474_0.png"/></p>
<h3>Quest Diagnostics 股价分析</h3>
<p>截至 2 月 6 日，Quest Diagnostics 的股价为 190.71 美元。在过去 52 周内，股价上涨了 14.38%。鉴于这些回报通常是积极的，长期股东在此次财报发布前应该感到满意。</p>
<p>要跟踪 Quest Diagnostics 的所有财报发布，请访问我们网站上的财报日历。</p>
<p><em>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</em></p>

奎斯特诊疗

<p>奎斯特诊疗 (NYSE:DGX) 将于 2026 年 2 月 10 日发布季度财报，分析师预测每股收益 (EPS) 为 2.35 美元。投资者期待在上个季度每股收益超出预期的基础上获得积极的指引，当时每股收益为 2.60 美元，导致股价下跌 1.88%。目前，股价为 190.71 美元，反映出过去一年上涨了 14.38%。长期股东在公告前可能持乐观态度</p>

<p><strong>Quest Diagnostics</strong> (NYSE: DGX) is set to give its latest quarterly earnings report on Tuesday, 2026-02-10. Here's what investors need to know before the announcement.</p>
<div class="lb-trans"><p><strong>Quest Diagnostics</strong>（纽约证券交易所代码：DGX）将于 2026 年 2 月 10 日发布最新的季度财报。在公告之前，投资者需要了解以下信息。</p>
</div><p>Analysts estimate that Quest Diagnostics will report an <strong>earnings per share</strong> (EPS) of $2.35.</p>
<div class="lb-trans"><p>分析师预计 Quest Diagnostics 的 <strong>每股收益</strong>（EPS）为 2.35 美元。</p>
</div><p>Anticipation surrounds Quest Diagnostics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<div class="lb-trans"><p>投资者对 Quest Diagnostics 的公告充满期待，希望听到超出预期的消息以及对下个季度的积极指引。</p>
</div><p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<div class="lb-trans"><p>新投资者应理解，虽然盈利表现很重要，但市场反应往往受到指引的驱动。</p>
</div><h3>Earnings History Snapshot</h3>
<div class="lb-trans"><h3>盈利历史快照</h3>
</div><p>In the previous earnings release, the company beat EPS by $0.09, leading to a 1.88% drop in the share price the following trading session.</p>
<div class="lb-trans"><p>在上一次财报发布中，公司每股收益超出预期 0.09 美元，导致随后的交易日股价下跌 1.88%。</p>
</div><p>Here's a look at Quest Diagnostics's past performance and the resulting price change:</p>
<div class="lb-trans"><p>以下是 Quest Diagnostics 的过往表现及其导致的价格变化：</p>
</div><table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th align="right"><strong>Q3 2025</strong></th>
<th align="right"><strong>Q2 2025</strong></th>
<th align="right"><strong>Q1 2025</strong></th>
<th align="right"><strong>Q4 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td align="right">2.51</td>
<td align="right">2.57</td>
<td align="right">2.15</td>
<td align="right">2.18</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td align="right">2.60</td>
<td align="right">2.62</td>
<td align="right">2.21</td>
<td align="right">2.23</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td align="right">-2.00</td>
<td align="right">-4.00</td>
<td align="right">0.00</td>
<td align="right">-1.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th><strong>季度</strong></th>
<th align="right"><strong>2025 年第三季度</strong></th>
<th align="right"><strong>2025 年第二季度</strong></th>
<th align="right"><strong>2025 年第一季度</strong></th>
<th align="right"><strong>2024 年第四季度</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS 预估</strong></td>
<td align="right">2.51</td>
<td align="right">2.57</td>
<td align="right">2.15</td>
<td align="right">2.18</td>
</tr>
<tr>
<td><strong>EPS 实际</strong></td>
<td align="right">2.60</td>
<td align="right">2.62</td>
<td align="right">2.21</td>
<td align="right">2.23</td>
</tr>
<tr>
<td><strong>价格变化 %</strong></td>
<td align="right">-2.00</td>
<td align="right">-4.00</td>
<td align="right">0.00</td>
<td align="right">-1.00</td>
</tr>
</tbody>
</table>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1770656474_0.png" alt="eps graph" original-src="https://www.benzinga.com/files/images/story/2026/1770656474_0.png"/></p>
<h3>Quest Diagnostics Share Price Analysis</h3>
<div class="lb-trans"><h3>Quest Diagnostics 股价分析</h3>
</div><p>Shares of Quest Diagnostics were trading at $190.71 as of February 06. Over the last 52-week period, shares are up 14.38%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.</p>
<div class="lb-trans"><p>截至 2 月 6 日，Quest Diagnostics 的股价为 190.71 美元。在过去 52 周内，股价上涨了 14.38%。鉴于这些回报通常是积极的，长期股东在此次财报发布前应该感到满意。</p>
</div><p>To track all earnings releases for Quest Diagnostics visit their earnings calendar on our site.</p>
<div class="lb-trans"><p>要跟踪 Quest Diagnostics 的所有财报发布，请访问我们网站上的财报日历。</p>
</div><p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>
<div class="lb-trans"><p><em>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</em></p>
</div>

奎斯特诊疗即将发布的财报分析